Search for: "Gibson Products Co., Inc. v. State" Results 41 - 60 of 72
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Oct 2012, 9:38 pm by Bill Marler
’” Brown, 607 F.2d at 700 (quoting Gibson Wine Co. v. [read post]
14 Mar 2016, 2:56 am by Kevin LaCroix
  In Avon State Bank, David Gibson, a man who purported to be the son of a business associate of Ambrose Herdering, a customer of Avon State Bank, sought out the assistance of Herdering in moving the estate of Gibson’s deceased father from the Netherlands to the United States. [read post]
31 May 2007, 4:31 am
Warner-Lambert Co., 326 F.3d 339, 347 (2d Cir. 2003); Thompson v. [read post]
28 May 2009, 11:26 am
Gibson, 355 U.S. 41 (1957), interpreted Rule 8 as precluding the dismissal of a complaint for failure to state a claim (meaning that the complaint was inadequately pleaded on its face) "unless it appears beyond doubt that the plaintiff can prove no set of facts in support of his claim which would entitle him to relief. [read post]
14 Feb 2009, 11:56 am
Gibson Dunn already is seeing a surge in labor and employment, consumer fraud, and products liability litigation. [read post]
21 Aug 2007, 5:11 am by David G. Badertscher
This development follows a recent problematic decision by the 2nd Circuit in AFSCME v. [read post]
21 Aug 2007, 1:10 am
This development follows a recent problematic decision by the 2nd Circuit in AFSCME v. [read post]
14 May 2016, 3:34 am by Florian Mueller
Further below you can find a very long list of items in the evidentiary record of Oracle v. [read post]
14 May 2015, 7:28 am
Questions about the safety and efficacy of FDA-approved uses of medical products persist long after their entry onto the market. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
18 Mar 2010, 2:47 pm by Beck, et al.
Gibson, 355 U.S. 41 (1957), formulation. [read post]